1 enrolling by invitation, 1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow Mabylon AG: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy MY006 Low Dose, MY006 Mid Dose, MY006 High Dose - Peanut Allergies | Phase 1 | Recruiting | Mabylon AG | 48 | 2025-12-06 | 2026-10-20 |
| Identification of Allergen-reactive Antibodies in the Blood of Pollen Allergic Patients blood withdrawal - Pollen Allergy | Enrolling by invitation | Mabylon AG | 300 | 2018-10-01 | 2026-10-22 |
Peanut Hypersensitivity (1) · Rhinitis, Allergic, Seasonal (1)
Switzerland (1) · United States (1)
2018 (1)